₩36,800.00
1.38%
Korea, Oct 19, 01:44 pm KST. Market open.
ISIN
KR7302440003
Symbol
302440
Index

SK Bioscience Stock price

₩36,300.00
+100.00 0.28% 1M
-8,350.00 18.70% 6M
-11,900.00 24.69% YTD
-11,600.00 24.22% 1Y
-29,700.00 45.00% 3Y
-194,200.00 84.25% 5Y
-132,700.00 78.52% 10Y
-132,700.00 78.52% 20Y
Korea, Closing price Fri, Oct 16 2026
+950.00 2.69%
ISIN
KR7302440003
Symbol
302440
Index
Industry

Is SK Bioscience a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.

Key metrics

Basic
Market capitalization
₩2.8t
Enterprise Value
₩2.5t
Net debt
positive
Cash
₩831.0b
Shares outstanding
78.0m
Valuation
P/E
negative
P/S | estimate
4.2 | 3.9
EV/Sales | estimate
3.8 | 3.5
EV/FCF | ex SBC
negative | -
P/B
1.6
Financial Health
Equity Ratio
60.5%
Return on Equity
-3.2%
ROCE
-5.0%
ROIC
-5.8%
Debt/Equity
0.3
Financials
Revenue | estimate
₩659.3b | ₩706.2b
EBITDA
₩-111.1b
EBIT
₩-131.2b
Net Income
₩-84.7b
Free Cash Flow | ex SBC
₩-259.1b | -
Growth
Revenue | estimate
23.3% | 8.4%
EBITDA
3.1%
EBIT
-2.9%
Net Income
-60.7%
Free Cash Flow
-20.0%
Margin
Gross
14.3%
EBITDA
-16.9%
EBIT
-19.9%
Net
-12.9%
Free Cash Flow | ex SBC
-39.3% | -
More
EPS
₩-1,084.3
FCF per Share
₩-3,320.3
Short interest
-
Employees
917
Rev per Employee
₩710.3m

SK Bioscience Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a SK Bioscience forecast:

2x Buy
17%
4x Hold
33%
6x Sell
50%

Analyst Opinions

12 Analysts have issued a SK Bioscience forecast:

Buy
17%
Hold
33%
Sell
50%

SK Bioscience Events

Upcoming Event
NOV
2
Q3 2026 Earnings Call
in 14 days
View Past Earnings Reaction

Financial data from SK Bioscience

Jun '26
+/-
%
659,267 659,267
23% 23%
100%
- Direct Costs 564,992 564,992
15% 15%
86%
94,275 94,275
107% 107%
14%
- Selling and Administrative Expenses 132,594 132,594
20% 20%
20%
- Research and Development Expense 72,838 72,838
12% 12%
11%
-111,093 -111,093
3% 3%
-17%
- Depreciation and Amortization 20,096 20,096
57% 57%
3%
EBIT (Operating Income) EBIT -131,190 -131,190
3% 3%
-20%
Net Profit -84,699 -84,699
61% 61%
-13%

In millions KRW.

Don't miss a Thing! We will send you all news about SK Bioscience directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company was founded on July 1, 2018 and is headquartered in Seongnam-si, South Korea.

Head office South Korea
CEO Mr. Ahn
Employees 917
Founded 2008
Website www.skbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today